Bolt Biotherapeutics, Inc. (BOLT) Social Stream
BOLT BIOTHERAPEUTICS INC (BOLT) Price Targets From Analysts
Use the tables below to see what analysts covering BOLT BIOTHERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-16 | 4 | $45 | $35 | $39.75 | $1.14 | 3386.84% |
| 2021-11-10 | 4 | $45 | $33 | $38.5 | $1.14 | 3277.19% |
| 2021-12-06 | 4 | $45 | $19 | $34.75 | $1.14 | 2948.25% |
| 2022-01-06 | 4 | $42 | $11 | $26.25 | $1.14 | 2202.63% |
| 2022-02-01 | 1 | $33 | $7 | $19.666 | $1.14 | 1625.09% |
| 2022-04-12 | 3 | $33 | $7 | $18.666 | $1.14 | 1537.37% |
| 2022-05-03 | 3 | $16 | $7 | $10.333 | $1.14 | 806.4% |
| 2022-08-01 | 3 | $13 | $5 | $8.666 | $1.14 | 660.18% |
| 2022-09-06 | 4 | $7 | $4 | $5.333 | $1.14 | 367.81% |
| 2022-11-23 | 3 | $8 | $4 | $6 | $1.14 | 426.32% |
| 2023-04-03 | 4 | $8 | $3 | $5.5 | $1.14 | 382.46% |
| 2023-05-15 | 4 | $8 | $3.001 | $5.5 | $1.14 | 382.46% |
| 2023-08-08 | 4 | $8 | $3 | $5.5 | $1.14 | 382.46% |
| 2023-08-17 | 4 | $8 | $3 | $5.25 | $1.14 | 360.53% |
| 2023-11-17 | 4 | $8 | $3 | $5 | $1.14 | 338.6% |
| 2023-12-19 | 4 | $8 | $1.25 | $4.562 | $1.14 | 300.18% |
Price Target Last Issued February 1, 2022
The Trend in the Analyst Price Target
BOLT's average price target has moved down $34.94 over the prior 29 months.
Over the past 47 weeks, BOLT's average upside potential has been 300.74%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-31 | 4 | 8 | 3.00 | 5.500 | 1.39 | 295.68% |
| 2023-04-03 | 4 | 8 | 3.00 | 5.500 | 1.43 | 284.62% |
| 2023-08-08 | 4 | 8 | 3.00 | 5.500 | 1.30 | 323.08% |
| 2023-11-10 | 4 | 8 | 3.00 | 5.000 | 0.97 | 415.46% |
| 2023-12-19 | 4 | 8 | 1.25 | 4.562 | 1.00 | 356.2% |
BOLT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
BOLT's average broker recommendation rating worsened by 0.25 over the prior 28 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- BOLT has a higher upside potential (average analyst target price relative to current price) than 2009.17% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, BOLT BIOTHERAPEUTICS INC's number of analysts covering the stock is greater than 220.21% of them.
- In terms of how BOLT BIOTHERAPEUTICS INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1538.1% of that group.
- BOLT has a greater average analyst price target than 513.24% of Healthcare stocks.
In the Pharmaceutical Products industry, LABP, TERN, and SNSE are the three stocks most similar to BOLT BIOTHERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding BOLT using the data that counts. Try POWR Ratings for free.